Vigabatrin for infantile spasms

Pediatric Neurology

Volumn 27, Issue 3, 2002, Pages 161-164

  Mitchell, Wendy G ^a   Shah, Namrata S ^b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; CORTICOTROPIN; LAMOTRIGINE; PHENOBARBITAL; PYRIDOXINE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; ELECTROENCEPHALOGRAM; HUMAN; HYPSARRHYTHMIA; INFANT; INFANTILE SPASM; PRESCHOOL CHILD; PRIORITY JOURNAL; SEIZURE; TREATMENT OUTCOME;

ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ELECTROENCEPHALOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; PRODUCT SURVEILLANCE, POSTMARKETING; RETROSPECTIVE STUDIES; SPASMS, INFANTILE; VIGABATRIN;

EID: 0036711433     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(02)00400-9     Document Type: Article

References (21)

1. Koo B., Hwang P.A., Logan W.J. Infantile spasms Outcome and prognostic factors of cryptogenic and symptomatic groups . Neurology. 43:1993;2322-2327.
2. Lombroso C.T. A prospective study of infantile spasms Clinical and therapeutic correlations . Epilepsia. 24:1983;135-158.
3. Aicardi J., Mumford J.P., Dumas C., Wood S. Vigabatrin as initial therapy for infantile spasms A European retrospective survey . Sabril IS Investigator and Peer Review Groups Epilepsia. 37:1996;638-642.
4. Fejerman N., Cersosimo R., Caraballo R., et al. Vigabatrin as a first-choice drug in the treatment of West syndrome. J Child Neurol. 15:2000;161-165.
5. Chiron C., Dulac O., Beaumont D., Palacios L., Pajot N., Mumford J. Therapeutic trial of vigabatrin in refractory infantile spasms. J Child Neurol. (Suppl 2):1991;S52-59.
6. Dulac O., Chiron C., Luna D., et al. Vigabatrin in childhood epilepsy. J Child Neurol. (Suppl 2):1991;S30-37.
7. Chiron C., Dumas C., Jambaque I., Mumford J., Dulac O. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res. 26:1997;389-395.
8. Vigevano F., Cilio M.R. Vigabatrin versus ACTH as first-line treatment for infantile spasms A randomized, prospective study . Epilepsia. 38:1997;1270-1274.
9. Cossette P., Riviello J.J., Carmant L. ACTH versus vigabatrin therapy in infantile spasms A retrospective study . Neurology. 52:1999;1691-1694.
10. Koo B. Vigabatrin in the treatment of infantile spasms. Pediatr Neurol. 20:1999;106-110.
11. Elterman R.D., Shields W.D., Mansfield K.A., Nakagawa J. Randomized trial of vigabatrin in patients with infantile spasms. Neurology. 57:2001;1416-1421.
12. Gross-Tsur V., Banin E., Shahar E., Shalev R.S., Lahat E. Visual impairment in children with epilepsy treated with vigabatrin. Ann Neurol. 48:2000;60-64.
13. Hardus P., Verduin W.M., Engelsman M., et al. Visual field loss associated with vigabatrin Quantification and relation to dosage . Epilepsia. 42:2001;262-267.
14. Iannetti P., Spalice A., Perla F.M., Conicella E., Raucci U., Bizzarri B. Visual field constriction in children with epilepsy on vigabatrin treatment. Pediatrics. 106:2000;838-842.
15. Russell-Eggitt I.M., Mackey D.A., Taylor D.S., Timms C., Walker J.W. Vigabatrin-associated visual field defects in children. Eye. 14:2000;334-339.
16. Cohen J.A., Fisher R.S., Brigell M.G., Peyster R.G., Sze G. The potential for vigabatrin-induced intramyelinic edema in humans. Epilepsia. 41:2000;148-157.
17. Snead 3rd O.C., Benton Jr J.W., Hosey L.C., et al. Treatment of infantile spasms with high-dose ACTH Efficacy and plasma levels of ACTH and cortisol . Neurology. 39:1989;1027-1031.
18. Baram T.Z., Mitchell W.G., Tournay A., Snead O.C., Hanson R.A., Horton E.J. High-dose corticotropin (ACTH) versus prednisone for infantile spasms A prospective, randomized, blinded study . Pediatrics. 97:1996;375-379.
19. Glauser T.A., Clark P.O., Strawsburg R. A pilot study of topiramate in the treatment of infantile spasms. Epilepsia. 39:1998;1324-1328.
20. Johnson M.A., Krauss G.L., Miller N.R., Medura M., Paul S.R. Visual function loss from vigabatrin Effect of stopping the drug . Neurology. 55:2000;40-45.
21. Miller N.R. Using the electroretinogram to detect and monitor the retinal toxicity of anticonvulsants. Neurology. 55:2000;333-334.